Inventor
SANDHAM DAVID ANDREW
GB20 patents
⚠️ This page may combine multiple inventors who share the name “SANDHAM DAVID ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
15 patentsUS7666878B2Feb 23, 2010
Pyrrolopyridine derivatives and their use as Crth2 antagonists
NOVARTIS AG16 citations91
US6921757B2Jul 26, 2005
Organic compounds
NOVARTIS AG34 citations90
US7745462B2Jun 29, 2010
Quinoline-2-one derivatives for the treatment of airways diseases
NOVARTIS AG7 citations71
US11708366B2Jul 25, 2023
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
NOVARTIS AG2 citations69
US9403810B2Aug 2, 2016
Carboxamide derivatives
NOVARTIS AG3 citations69
US6919337B2Jul 19, 2005
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
NOVARTIS AG9 citations69
US8791256B2Jul 29, 2014
Pyrrolopyridine derivatives and their use as CRTH2 antagonists
NOVARTIS AG1 citations61
US11672782B2Jun 13, 2023
Carboxamide derivatives
NOVARTIS AG0 citations59
US12157737B2Dec 3, 2024
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
NOVARTIS AG0 citations58
US9169251B2Oct 27, 2015
Pyrrolopyridine derivatives and their use as CRTH2 antagonists
NOVARTIS AG0 citations51
US7888383B2Feb 15, 2011
Organic compounds
NOVARTIS AG1 citations51
US7019136B2Mar 28, 2006
8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
NOVARTIS AG0 citations50
US10195181B2Feb 5, 2019
Carboxamide derivatives
NOVARTIS AG0 citations48
US10183025B2Jan 22, 2019
Autotaxin inhibitors
NOVARTIS AG0 citations47
US9763957B2Sep 19, 2017
Autotaxin inhibitors
NOVARTIS AG1 citations47